Over the past decade, messenger RNA (mRNA) has emerged as potent and flexible platform
for the development of novel effective cancer immunotherapies. Advances in non-viral gene …

Background Cancer remains a serious health concern worldwide, and different approaches
are being developed for its treatment. The strategy to use the immune system as an …

Cancer immunotherapy, which harnesses the power of the immune system, has shown
immense promise in the fight against malignancies. Messenger RNA (mRNA) stands as a …

Abstract mRNA therapeutics have emerged as powerful tools for cancer immunotherapy in
accordance with their superiority in expressing all sequence‐known proteins in vivo. In …

Messenger RNA (mRNA) is now in the limelight as a powerful tool for treating various
human diseases, especially malignant tumors, thanks to the remarkable clinical outcomes of …

Abstract mRNA molecules hold tremendous potential as a tool for gene therapy of a wide
range of diseases. However, the main hurdle in implementation of mRNA for therapeutics …

The induction of a potent T cell response is essential for successful tumor immunotherapy
and protection against many infectious diseases. In the past few years, mRNA vaccines …

The induction of a strong cytotoxic T cell response is an important prerequisite for successful
immunotherapy against many viral diseases and tumors. Nucleotide vaccines, including …

Nucleic acid-based therapies such as messenger RNA have the potential to revolutionize
modern medicine and enhance the performance of existing pharmaceuticals. The key …

Harnessing mRNA–lipid nanoparticles (LNPs) to treat patients with cancer has been an
ongoing research area that started before these versatile nanoparticles were successfully …